Heart Rate Variability-Guided Exercise Training in Type 2 Diabetes
The trial, sponsored by the University of Illinois at Chicago, aimed to evaluate a novel approach to exercise training for individuals with type 2 diabetes by utilizing heart rate variability (HRV) to tailor exercise prescriptions. Despite the innovative nature of this intervention, the study was withdrawn due to challenges in participant enrollment and funding cessation. The market for diabetes management solutions is substantial, with increasing demand for personalized treatment options. Companies focusing on exercise-based interventions may find competitive advantages in developing similar HRV-guided programs, especially as the prevalence of type 2 diabetes continues to rise. Diligence should consider the feasibility of recruitment strategies and funding mechanisms for future studies.
Indication: Type 2 Diabetes
Modality: combination therapy
Target: Heart rate variability as a guide for exercise prescription in individuals with type 2 diabetes.
Sponsor: University of Illinois at Chicago
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 09, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Heart rate variability as a guide for exercise prescription in individuals with type 2 diabetes.
View original source fields
Condition raw: Type 2 Diabetes, Diabetes Mellitus, Type 2, Type 2 Diabetes Mellitus in Obese
Condition normalized: Type 2 Diabetes, Diabetes Mellitus, Type 2, Type 2 Diabetes Mellitus in Obese
Modality raw: combination therapy
Modality normalized: combination therapy
Target raw: Heart rate variability as a guide for exercise prescription in individuals with type 2 diabetes.
Target normalized: Heart rate variability as a guide for exercise prescription in individuals with type 2 diabetes.